Table 3.

Clinical outcomes in 24 months.

	All (n = 1,071)	H-FABP < 4.143 ng/mL, (n = 843)	H-FABP ≧ 4.143 ng/mL, (n = 228)	p
Primary outcome
Total CV events, n (%)	207 (19.33%)	133 (15.78%)	74 (32.46%)	<0.001
Secondary outcome
CV or cerebrovascular death, n (%)	12 (1.12%)	1 (0.12%)	11 (4.82%)	<0.001
Nonfatal myocardial infarction, n (%)	24 (2.24%)	16 (1.9%)	8 (3.51%)	0.145
Nonfatal stroke, n (%)	6 (0.56%)	3 (0.36%)	3 (1.32%)	0.085
Acute heart failure-related hospitalization, n (%)	16 (1.49%)	8 (0.95%)	8 (3.51%)	0.005
Total CV events except for angina-related hospitalization, n (%)	80 (7.47%)	38 (4.51%)	42(18.00%)	<0.001

CV = cardiovascular.